TORONTO and NEW YORK, Oct. 10,
2017 /CNW/ - AcuityAds Holdings Inc. (TSXV:AT) ("AcuityAds" or "Company"), a technology leader that provides targeted
digital media solutions enabling advertisers to connect intelligently with audiences across video, mobile, social and online
display campaigns, today announced that it received an order from a global pharmaceutical company totaling $750,000 CDN. This global pharmaceutical company will be running multiple digital advertising campaigns
throughout the U.S. in the fourth quarter in support of a brand re-launch for one of their over-the-counter medicines.
AcuityAds acquired 140 Proof for its social signal-based mobile offering and acquired Visible Measures for its analytics-led
video offering. The integrated company enables its sales force to provide a more powerful holistic solution and engage in
expanded conversations with brands to capture a greater share of their digital advertising spend.
"This win highlights the expanded value proposition that we can offer marketers looking to garner real returns and those
seeking a greater share of audience attention from their advertising initiatives," stated Tal
Hayek, CEO of AcuityAds. "It also validates that we are seeing a significant increase in the average order
size."
Additionally, the Company is pleased to announce that it was recently recognized as the fifth fastest growing Canadian
software company in Canada and ranked #18 overall on the 2017 PROFIT 500 Ranking of Canada's Fastest Growing Companies.
About AcuityAds:
AcuityAds is a technology company that enables marketers to connect intelligently with their most meaningful audiences through
digital media. A Self-Serve programmatic marketing platform, powered by machine learning, is at the core of our business. This is
accompanied by strategic digital advertising solutions that cater to social, mobile and video-specific needs. AcuityAds empowers
marketers by offering transparency on costs and brand safety, and real-time reporting and analytics, bringing accountability to
programmatic advertising to deliver business results.
AcuityAds is headquartered in Toronto, Canada with sales offices in New York City, Boston, Chicago,
Los Angeles, San Francisco, San
Diego, Dallas, Vancouver, Calgary, Montreal and London, England. For
more information, visit AcuityAds.com.
Disclaimer in regards to Forward-looking Statements
Certain statements included herein constitute "forward-looking statements" within the meaning of applicable securities laws.
Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by
management at this time, are inherently subject to significant business, economic and competitive uncertainties and
contingencies. Investors are cautioned not to put undue reliance on forward-looking statements. Except as required by law,
AcuityAds does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new
information or future events. The Company's client that has been mentioned in this press release has the right to exercise
an out clause right at any time during the advertising campaign.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE AcuityAds Inc.
View original content: http://www.newswire.ca/en/releases/archive/October2017/10/c8359.html